FDA’s Josh Sharfstein Takes “Acting” Title Literally
Executive Summary
Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on multiple fronts, quickly stepping up regulation and taking steps toward overhauling the agency's internal culture